Literature for peptidase A01.059: plasmepsin-4
(Topics flags: S Structure, T Target, K Knockout, P Specificity, I Inhibitor, E Expression, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)
-
Zogota,R., Kinena,L., Withers-Martinez,C., Blackman,M.J., Bobrovs,R., Pantelejevs,T., Kanepe-Lapsa,I., Ozola,V., Jaudzems,K., Suna,E. and Jirgensons,A.
Peptidomimetic plasmepsin inhibitors with potent anti-malarial activity and selectivity against cathepsin D
Eur J Med Chem163, 344-352. PubMed Europe PubMed DOI -
Kumar Singh,A., Rajendran,V., Singh,S., Kumar,P., Kumar,Y., Singh,A., Miller,W., Potemkin,V., Poonam, Grishina,M., Gupta,N., Kempaiah,P., Durvasula,R., Singh,B.K., Dunn,B.M. and Rathi,B.
Antiplasmodial activity of hydroxyethylamine analogs: synthesis, biological activity and structure activity relationship of plasmepsin inhibitors
Bioorg Med Chem26, 3837-3844. PubMed Europe PubMed DOI I -
Onchieku,N.M., Mogire,R., Ndung'u,L., Mwitari,P., Kimani,F., Matoke-Muhia,D., Kiboi,D. and Magoma,G.
Deciphering the targets of retroviral protease inhibitors in Plasmodium berghei
PLoS ONE13, e0201556-e0201556. PubMed Europe PubMed DOI I -
Rasina,D., Stakanovs,G., Borysov,O.V., Pantelejevs,T., Bobrovs,R., Kanepe-Lapsa,I., Tars,K., Jaudzems,K. and Jirgensons,A.
2-Aminoquinazolin-4(3H)-one based plasmepsin inhibitors with improved hydrophilicity and selectivity
Bioorg Med Chem26, 2488-2500. PubMed Europe PubMed DOI I -
Pirta,C., Sharma,N.N. and Banyal,H.S.
A 43 kDa recombinant plasmepsin elicits immune response in mice against Plasmodium berghei malaria
Acta Parasitol61, 102-107. PubMed Europe PubMed DOI E -
Ponsuwanna,P., Kochakarn,T., Bunditvorapoom,D., Kumpornsin,K., Otto,T.D., Ridenour,C., Chotivanich,K., Wilairat,P., White,N.J., Miotto,O. and Chookajorn,T.
Comparative genome-wide analysis and evolutionary history of haemoglobin-processing and haem detoxification enzymes in malarial parasites
Malar J15, 51-51. PubMed Europe PubMed DOI -
Rasina,D., Otikovs,M., Leitans,J., Recacha,R., Borysov,O.V., Kanepe-Lapsa,I., Domraceva,I., Pantelejevs,T., Tars,K., Blackman,M.J., Jaudzems,K. and Jirgensons,A.
Fragment-based discovery of 2-aminoquinazolin-4(3h)-ones as novel class nonpeptidomimetic inhibitors of the plasmepsins I, II, and IV
J Med Chem59, 374-387. PubMed Europe PubMed DOI I -
Recacha,R., Jaudzems,K., Akopjana,I., Jirgensons,A. and Tars,K.
Crystal structure of Plasmodium falciparum proplasmepsin IV: the plasticity of proplasmepsins
Acta Crystallogr F Struct Biol Commun72, 659-666. PubMed Europe PubMed DOI S -
Liu,P., Robbins,A.H., Marzahn,M.R., McClung,S.H., Yowell,C.A., Stevens SM Jr, Dame,J.B. and Dunn,B.M.
Enzymatic characterization of recombinant food vacuole plasmepsin 4 from the rodent malaria parasite Plasmodium berghei
PLoS ONE10, e0141758-e0141758. PubMed Europe PubMed DOI P I -
McGillewie,L. and Soliman,M.E.
Flap flexibility amongst plasmepsins I, II, III, IV, and V: sequence, structural, and molecular dynamics analyses
Proteins83, 1693-1705. PubMed Europe PubMed DOI -
Singh,A.K., Rathore,S., Tang,Y., Goldfarb,N.E., Dunn,B.M., Rajendran,V., Ghosh,P.C., Singh,N., Latha,N., Singh,B.K., Rawat,M. and Rathi,B.
Hydroxyethylamine based phthalimides as new class of plasmepsin hits: design, synthesis and antimalarial evaluation
PLoS ONE10, e0139347-e0139347. PubMed Europe PubMed DOI I -
Jaudzems,K., Tars,K., Maurops,G., Ivdra,N., Otikovs,M., Leitans,J., Kanepe-Lapsa,I., Domraceva,I., Mutule,I., Trapencieris,P., Blackman,M.J. and Jirgensons,A.
Plasmepsin inhibitory activity and structure-guided optimization of a potent hydroxyethylamine-based antimalarial hit
ACS Med Chem Lett5, 373-377. PubMed Europe PubMed DOI I -
Meyers,M.J., Tortorella,M.D., Xu,J., Qin,L., He,Z., Lang,X., Zeng,W., Xu,W., Qin,L., Prinsen,M.J., Sverdrup,F.M., Eickhoff,C.S., Griggs,D.W., Oliva,J., Ruminski,P.G., Jacobsen,E.J., Campbell,M.A., Wood,D.C., Goldberg,D.E., Liu,X., Lu,Y., Lu,X., Tu,Z., Lu,X., Ding,K. and Chen,X.
Evaluation of aminohydantoins as a novel class of antimalarial agents
ACS Med Chem Lett5, 89-93. PubMed Europe PubMed DOI I -
Aureggi,V., Ehmke,V., Wieland,J., Schweizer,W.B., Bernet,B., Bur,D., Meyer,S., Rottmann,M., Freymond,C., Brun,R., Breit,B. and Diederich,F.
Potent inhibitors of malarial aspartic proteases, the plasmepsins, by hydroformylation of substituted 7-azanorbornenes
Chemistry19, 155-164. PubMed Europe PubMed DOI I -
Chugh,M., Sundararaman,V., Kumar,S., Reddy,V.S., Siddiqui,W.A., Stuart,K.D. and Malhotra,P.
Protein complex directs hemoglobin-to-hemozoin formation in Plasmodium falciparum
Proc Natl Acad Sci U S A110, 5392-5397. PubMed Europe PubMed DOI -
Berry,C. and Goldberg,D.E.
Food vacuole plasmepsins
[ISSN:978-0-12-407744-7]3, 98-103. DOI -
Bhaumik,P., Gustchina,A. and Wlodawer,A.
Structural studies of vacuolar plasmepsins
Biochim Biophys Acta1824, 207-223. PubMed Europe PubMed DOI S -
Meyers,M.J. and Goldberg,D.E.
Recent advances in plasmepsin medicinal chemistry and implications for future antimalarial drug discovery efforts
Curr Top Med Chem12, 445-455. PubMed Europe PubMed DOI I -
Gil,L., Valiente,P.A., Pascutti,P.G. and Pons,T.
Computational perspectives into plasmepsins structure-function relationship: implications to inhibitors design
J Trop Med2011, 657483-657483. PubMed Europe PubMed DOI V -
McKay,P.B., Peters,M.B., Carta,G., Flood,C.T., Dempsey,E., Bell,A., Berry,C., Lloyd,D.G. and Fayne,D.
Identification of plasmepsin inhibitors as selective anti-malarial agents using ligand based drug design
Bioorg Med Chem Lett21, 3335-3341. PubMed Europe PubMed DOI I -
Rawat,M., Vijay,S., Gupta,Y., Dixit,R., Tiwari,P.K. and Sharma,A.
Sequence homology and structural analysis of plasmepsin 4 isolated from Indian Plasmodium vivax isolates
Infect Genet Evol11, 924-933. PubMed Europe PubMed DOI -
Silva,N., Lameira,J. and Alves,C.N.
A quantum mechanical/molecular mechanical study of the aspartic protease plasmepsin IV complexed with allophenylnorstatine-based inhibitor
Chem Phys Lett509, 169-174. DOI I -
Spaccapelo,R., Aime,E., Caterbi,S., Arcidiacono,P., Capuccini,B., Di Cristina,M., Dottorini,T., Rende,M., Bistoni,F. and Crisanti,A.
Disruption of plasmepsin-4 and merozoites surface protein-7 genes in Plasmodium berghei induces combined virulence-attenuated phenotype
Sci Rep1, 39-39. PubMed Europe PubMed DOI K -
Li,F., Patra,K.P., Yowell,C.A., Dame,J.B., Chin,K. and Vinetz,J.M.
Apical surface expression of aspartic protease plasmepsin 4, a potential transmission-blocking target of the Plasmodium ookinete
J Biol Chem285, 8076-8083. PubMed Europe PubMed DOI -
Luksch,T., Blum,A., Klee,N., Diederich,W.E., Sotriffer,C.A. and Klebe,G.
Pyrrolidine derivatives as plasmepsin inhibitors: binding mode analysis assisted by molecular dynamics simulations of a highly flexible protein
ChemMedChem5, 443-454. PubMed Europe PubMed DOI I -
Spaccapelo,R., Janse,C.J., Caterbi,S., Franke-Fayard,B., Bonilla,J.A., Syphard,L.M., Di Cristina,M., Dottorini,T., Savarino,A., Cassone,A., Bistoni,F., Waters,A.P., Dame,J.B. and Crisanti,A.
Plasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria
Am J Pathol176, 205-217. PubMed Europe PubMed DOI K -
Fah,C., Hardegger,L.A., Baitsch,L., Schweizer,W.B., Meyer,S., Bur,D. and Diederich,F.
New organofluorine building blocks: inhibition of the malarial aspartic proteases plasmepsin II and IV by alicyclic alpha,alpha-difluoroketone hydrates
Org Biomol Chem7, 3947-3957. PubMed Europe PubMed DOI I -
Moura,P.A., Dame,J.B. and Fidock,D.A.
Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors
Antimicrobial Agents Chemother53, 4968-4978. PubMed Europe PubMed DOI I -
Orrling,K.M., Marzahn,M.R., Gutierrez-de-Teran,H., Aqvist,J., Dunn,B.M. and Larhed,M.
alpha-Substituted norstatines as the transition-state mimic in inhibitors of multiple digestive vacuole malaria aspartic proteases
Bioorg Med Chem17, 5933-5949. PubMed Europe PubMed DOI I -
Janka,L., Clemente,J., Vaiana,N., Sparatore,A., Romeo,S. and Dunn,B.M.
Targeting the plasmepsin 4 orthologs of Plasmodium sp. with "double drug" inhibitors
Protein Pept Lett15, 868-873. PubMed Europe PubMed DOI T I -
Luksch,T., Chan,N.S., Brass,S., Sotriffer,C.A., Klebe,G. and Diederich,W.E.
Computer-aided design and synthesis of nonpeptidic plasmepsin II and IV inhibitors
ChemMedChem3, 1323-1336. PubMed Europe PubMed DOI I -
Bonilla,J.A., Bonilla,T.D., Yowell,C.A., Fujioka,H. and Dame,J.B.
Critical roles for the digestive vacuole plasmepsins of Plasmodium falciparum in vacuolar function
Mol Microbiol65, 64-75. PubMed Europe PubMed DOI K -
Bonilla,J.A., Moura,P.A., Bonilla,T.D., Yowell,C.A., Fidock,D.A. and Dame,J.B.
Effects on growth, hemoglobin metabolism and paralogous gene expression resulting from disruption of genes encoding the digestive vacuole plasmepsins of Plasmodium falciparum
Int J Parasitol37, 317-327. PubMed Europe PubMed DOI K -
Kasam,V., Zimmermann,M., Maass,A., Schwichtenberg,H., Wolf,A., Jacq,N., Breton,V. and Hofmann-Apitius,M.
Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid
J Chem Inf Model47, 1818-1828. PubMed Europe PubMed DOI I -
Andrews,K.T., Fairlie,D.P., Madala,P.K., Ray,J., Wyatt,D.M., Hilton,P.M., Melville,L.A., Beattie,L., Gardiner,D.L., Reid,R.C., Stoermer,M.J., Skinner-Adams,T., Berry,C. and McCarthy,J.S.
Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria
Antimicrob Agents Chemother50, 639-648. PubMed Europe PubMed DOI I -
Boss,C., Corminboeuf,O., Grisostomi,C., Meyer,S., Jones,A.F., Prade,L., Binkert,C., Fischli,W., Weller,T. and Bur,D.
Achiral, cheap, and potent inhibitors of plasmepsins I, II, and IV
ChemMedChem1, 1341-1345. PubMed Europe PubMed DOI S I -
Clemente,J.C., Govindasamy,L., Madabushi,A., Fisher,S.Z., Moose,R.E., Yowell,C.A., Hidaka,K., Kimura,T., Hayashi,Y., Kiso,Y., Agbandje-McKenna,M., Dame,J.B., Dunn,B.M. and McKenna,R.
Structure of the aspartic protease plasmepsin 4 from the malarial parasite Plasmodium malariae bound to an allophenylnorstatine-based inhibitor
Acta Crystallogr D Biol Crystallogr62, 246-252. PubMed Europe PubMed DOI S I -
[YEAR:21-11-2006]Ersmark,K., Nervall,M., Gutierrez-de-Teran,H., Hamelink,E., Janka,L.K., Clemente,J.C., Dunn,B.M., Gogoll,A., Samuelsson,B., Qvist,J. and Hallberg,A.
Macrocyclic inhibitors of the malarial aspartic proteases plasmepsin I, II, and IV
Bioorg Med Chem14, 2197-2208. PubMed Europe PubMed DOI I -
[YEAR:30-10-2006]Gutierrez-de-Teran,H., Nervall,M., Dunn,B.M., Clemente,J.C. and Aqvist,J.
Computational analysis of plasmepsin IV bound to an allophenylnorstatine inhibitor
FEBS Lett580, 5910-5916. PubMed Europe PubMed DOI I -
[YEAR:5-9-2006]Gutierrez-de-Teran,H., Nervall,M., Ersmark,K., Liu,P., Janka,L.K., Dunn,B., Hallberg,A. and Aqvist,J.
Inhibitor binding to the plasmepsin IV aspartic protease from Plasmodium falciparum
Biochemistry45, 10529-10541. PubMed Europe PubMed DOI I -
Hof,F., Schutz,A., Fah,C., Meyer,S., Bur,D., Liu,J., Goldberg,D.E. and Diederich,F.
Starving the malaria parasite: inhibitors active against the aspartic proteases plasmepsins I, II, and IV
Angew Chem Int Ed Engl45, 2138-2141. PubMed Europe PubMed DOI I -
Kim,Y.M., Lee,M.H., Piao,T.G., Lee,J.W., Kim,J.H., Lee,S., Choi,K.M., Jiang,J.H., Kim,T.U. and Park,H.
Prodomain processing of recombinant plasmepsin II and IV, the aspartic proteases of Plasmodium falciparum, is auto- and trans-catalytic
J Biochem139, 189-195. PubMed Europe PubMed DOI -
[YEAR:6-6-2006]Liu,J., Istvan,E.S., Gluzman,I.Y., Gross,J. and Goldberg,D.E.
Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems
Proc Natl Acad Sci U S A103, 8840-8845. PubMed Europe PubMed DOI -
[YEAR:15-2-2005]Beyer,B.B., Johnson,J.V., Chung,A.Y., Li,T., Madabushi,A., Agbandje-McKenna,M., McKenna,R., Dame,J.B. and Dunn,B.M.
Active-site specificity of digestive aspartic peptidases from the four species of Plasmodium that infect humans using chromogenic combinatorial peptide libraries
Biochemistry44, 1768-1779. PubMed Europe PubMed DOI I -
[YEAR:22-9-2005]Ersmark,K., Nervall,M., Hamelink,E., Janka,L.K., Clemente,J.C., Dunn,B.M., Blackman,M.J., Samuelsson,B., Aqvist,J. and Hallberg,A.
Synthesis of malarial plasmepsin inhibitors and prediction of binding modes by molecular dynamics simulations
J Med Chem48, 6090-6106. PubMed Europe PubMed DOI I -
[YEAR:28-10-2005]Liu,J., Gluzman,I.Y., Drew,M.E. and Goldberg,D.E.
The role of Plasmodium falciparum food vacuole plasmepsins
J Biol Chem280, 1432-1437. PubMed Europe PubMed DOI -
[YEAR:1-2-2005]Madabushi,A., Chakraborty,S., Fisher,S.Z., Clemente,J.C., Yowell,C., Agbandje-McKenna,M., Dame,J.B., Dunn,B.M. and McKenna,R.
Crystallization and preliminary X-ray analysis of the aspartic protease plasmepsin 4 from the malarial parasite Plasmodium malariae
Acta Crystallograph Sect F Struct Biol Cryst Commun61, 228-231. PubMed Europe PubMed DOI S I -
Berry,C. and Goldberg,D.E.
Plasmepsins
[ISSN:0-12-079610-4]2, 70-73. V -
Li,T., Yowell,C.A., Beyer,B.B., Hung,S.H., Westling,J., Lam,M.T., Dunn,B.M. and Dame,J.B.
Recombinant expression and enzymatic subsite characterization of plasmepsin 4 from the four Plasmodium species infecting man
Mol Biochem Parasitol135, 101-109. PubMed Europe PubMed DOI -
[YEAR:24-12-2004]Omara-Opyene,A.L., Moura,P.A., Sulsona,C.R., Bonilla,J.A., Yowell,C.A., Fujioka,H., Fidock,D.A. and Dame,J.B.
Genetic disruption of the Plasmodium falciparum digestive vacuole plasmepsins demonstrates their functional redundancy
J Biol Chem279, 54088-54096. PubMed Europe PubMed DOI -
Banerjee,R., Francis,S.E. and Goldberg,D.E.
Food vacuole plasmepsins are processed at a conserved site by an acidic convertase activity in Plasmodium falciparum
Mol Biochem Parasitol129, 157-165. PubMed Europe PubMed DOI -
[YEAR:11-8-2003]Dame,J.B., Yowell,C.A., Omara-Opyene,L., Carlton,J.M., Cooper,R.A. and Li,T.
Plasmepsin 4, the food vacuole aspartic proteinase found in all Plasmodium spp. infecting man
Mol Biochem Parasitol130, 1-12. PubMed Europe PubMed DOI -
[YEAR:22-7-2003]Nezami,A., Kimura,T., Hidaka,K., Kiso,A., Liu,J., Kiso,Y., Goldberg,D.E. and Freire,E.
High-affinity inhibition of a family of Plasmodium falciparum proteases by a designed adaptive inhibitor
Biochemistry42, 8459-8464. PubMed Europe PubMed DOI I -
[YEAR:22-1-2002]Banerjee,R., Liu,J., Beatty,W., Pelosof,L., Klemba,M. and Goldberg,D.E.
Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine
Proc Natl Acad Sci U S A99, 990-995. PubMed Europe PubMed DOI -
Nezami,A. and Freire,E.
The integration of genomic and structural information in the development of high affinity plasmepsin inhibitors
Int J Parasitol32, 1669-1676. PubMed Europe PubMed DOI I -
[YEAR:27-2-2002]Wyatt,D.M. and Berry,C.
Activity and inhibition of plasmepsin IV, a new aspartic proteinase from the malaria parasite, Plasmodium falciparum
FEBS Lett513, 159-162. PubMed Europe PubMed DOI -
Coombs,G.H., Goldberg,D.E., Klemba,M., Berry,C., Kay,J. and Mottram,J.C.
Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets
Trends Parasitol17, 532-537. PubMed Europe PubMed DOI -
[YEAR:10-12-1999]Humphreys,M.J., Moon,R.P., Klinder,A., Fowler,S.D., Rupp,K., Bur,D., Ridley,R.G. and Berry,C.
The aspartic proteinase from the rodent parasite Plasmodium berghei as a potential model for plasmepsins from the human malaria parasite, Plasmodium falciparum
FEBS Lett463, 43-48. PubMed Europe PubMed DOI
2019
2018
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
1999
